| Literature DB >> 35854865 |
Tara Zielke1, Miri Kim2, Joshua E Simon2, Ewa Borys3, Vikram C Prabhu2, Suguna Pappu2,4.
Abstract
BACKGROUND: Hypertrophic cranial pachymeningitis is a rare inflammatory disorder characterized by thickening of the dura mater and multiple cranial neuropathies. Although an infectious etiology may be present, often no specific cause is discovered. OBSERVATIONS: The authors described a 71-year-old man with progressive right eye vision loss, ptosis, and complete ophthalmoplegia with imaging findings suggestive of hypertrophic cranial pachymeningitis. Extensive studies, including cerebrospinal fluid studies, showed negative results. Blood serum, cell-free evaluation, and paraffin-embedded dural tissue testing had positive results for Pseudomonas aeruginosa, which allowed treatment tailored to the organism and a salutary clinical outcome. LESSONS: The constellation of neurological and radiological findings may make a diagnosis difficult in an inflammatory setting. The most precise methodology for establishing a diagnosis involves sampling the dura and testing it for infectious pathology. However, if results are inconclusive, further cell-free serum sampling with next-generation sequencing is a viable option for identifying pathogens with infectious concerns. This case highlighted the importance of multimodality studies for identifying a targetable pathogen.Entities:
Keywords: hypertrophic cranial pachymeningitis; CRP = C-reactive protein; CSF = cerebrospinal fluid; HCP = hypertrophic cranial pachymeningitis; MRI = magnetic resonance imaging; PCR = polymerase chain reaction; Pseudomonas aeruginosa; orbital apex syndrome; rRNA = ribosomal ribonucleic acid
Year: 2021 PMID: 35854865 PMCID: PMC9245743 DOI: 10.3171/CASE20168
Source DB: PubMed Journal: J Neurosurg Case Lessons ISSN: 2694-1902
FIG. 1.T1-weighted post-gadolinium MRI scans of the brain in axial (A) and coronal (B) sections demonstrating diffuse right-sided dural enhancement (arrows).
FIG. 2.Hematoxylin and eosin–stained sections through the abnormal dural tissue. A: Original magnification ×1 (low magnification). B: Original magnification ×5. Microabscesses are noted with asterisks. C and D: Original magnification ×10. Stains demonstrate changes associated with chronic inflammation and microabscesses (outlined with arrowheads).
FIG. 3.Patient leukocytosis and inflammatory markers throughout his hospitalization. Blue circles indicate white blood cell (WBC) count in thousands per microliter (k/µL) on the left axis. Orange circles indicate erythrocyte sedimentation rate (ESR) in millimeters per hour (mm/hr) on the right axis (normal laboratory values 0–20). Gray circles indicate CRP in milligrams per deciliter (mg/dL) on the left axis (normal laboratory value < 0.3). The black arrow indicates time of surgery; the gray arrow indicates initiation of antibiotics.
FIG. 4.Postoperative and post-antibiotic T1-weighted post-gadolinium MRI scans demonstrate significant radiographic improvement of dural enhancement. Postoperative and post-antibiotic T1-weighted post-gadolinium MRI scans at 6 weeks in axial (A) and coronal (B) sections demonstrate significant improvement of dural enhancement (arrows). Repeat MRI at 6 months after surgery (C and D) demonstrates continued improvement of dural enhancement (arrows).